Leading Healthcare-Focused Investor Expands Capabilities to Provide Comprehensive Suite of Equity, Debt, Royalty, and Hybrid Financing Solutions for Commercial Stage Companies Industry Veterans Jeremy ...

Secretome Therapeutics, a clinical-stage biotechnology company developing novel therapies derived from neonatal cardiac ...

Something that often gets lost in discussions about climate change is the massive health benefits the world would realize by ceasing to burn fossil fuels. What’s more, a warming planet poses numerous ...

With China accounting for an ever-larger share of global drug R&D innovation, RA Capital wants to make sure its portfolio biotechs aren't missing out. To this end, the life sciences and healthcare ...

The number of companies touting the benefits of psychedelics for healthcare is rapidly growing, but not all biotech investors are on board yet. Boston, Massachusetts-based RA Capital has been an ...

A firm that invests in healthcare and life sciences has raised more than a quarter of $1 billion for a new venture fund. Boston-based RA Capital Management said Monday that it had closed its inaugural ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Life science-focused venture capital firms Atlas Venture, F-Prime Capital, RA Capital Management, and Osage University Partners (OUP) have partnered to create ...

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. RA Capital Management has formed a new blank-check ...

RA Capital Management has raised another $461 million to invest in private biotechs. The closing of the fund comes 15 months after RA Capital set up an inaugural venture fund that has already seen 25% ...

RA Capital released its latest quarterly 13F fund update with the SEC last week, showcasing new positions in the multi-stage healthcare and life science-focused fund. The Boston-based fund has emerged ...

RA Capital Management has several bets in emerging therapies that use a cell’s own systems to get rid of the proteins that cause disease. Those investments are in biotechs targeting problem proteins ...

Biotech investors are flooding into the mental health and neuroscience fields, and RA Capital is the latest to get in on the trend. The venture capital firm launched Eliem Therapeutics on Thursday, ...